E. Stack

Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

J. Jansson, T. Metz, J. F. Stevens, 2020, Trials.

Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

J. Jansson, T. Metz, J. F. Stevens, 2020, Trials.

Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45.

D. Hanes, E. Stack, L. Buttolph, 2022, Advances in integrative medicine.

Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial

M. Szyf, R. Bradley, D. Hanes, 2021, Aging.

Reversal of Epigenetic Age with Diet and Lifestyle in a Pilot Randomized Clinical Trial

M. Szyf, D. Hanes, E. Stack, 2020, medRxiv.

Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.

T. Metz, J. F. Stevens, R. Bradley, 2021, Molecular nutrition & food research.